000 03485nam a22005055i 4500
001 vtls000545094
003 RU-ToGU
005 20210922083226.0
007 cr nn 008mamaa
008 160915s2014 gw | s |||| 0|eng d
020 _a9783642545627
_9978-3-642-54562-7
024 7 _a10.1007/978-3-642-54562-7
_2doi
035 _ato000545094
040 _aSpringer
_cSpringer
_dRU-ToGU
050 4 _aRM315-334
072 7 _aMMGW
_2bicssc
072 7 _aMED105020
_2bisacsh
082 0 4 _a615.78
_223
245 1 0 _aPsychopharmacology and Pregnancy
_helectronic resource
_bTreatment Efficacy, Risks, and Guidelines /
_cedited by Megan Galbally, Martien Snellen, Andrew Lewis.
260 _aBerlin, Heidelberg :
_bSpringer Berlin Heidelberg :
_bImprint: Springer,
_c2014.
300 _aVI, 232 p. 2 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
505 0 _aIntroduction to Perinatal Psychiatry -- The Process of Obtaining Informed Consent: Including Medico-legal implications -- Methodology: How to Interpret the Literature and Level of Evidence -- Physiological Changes in Pregnancy, the Biology of Exposure and Psychopharmacology -- Outcomes for Mother and Child as a Result of Untreated Mental Illness -- Major Depressive Disorders: Anti-depressants -- Anxiety Disorders: Anxiolytics and Hypnotics -- Bipolar Affective Disorder: Mood Stabilisers -- Schizophrenia: Anti-Psychotics -- Other Disorders: Eating Disorders, Borderline Personality Disorder -- Substance Abuse Disorders -- Complementary and alternative Medicines -- ECT -- Conclusion.
520 _aThis book examines the role of psychopharmacological treatment in a range of disorders that may be encountered during pregnancy, including major depressive disorders, anxiety disorders, bipolar affective disorder, schizophrenia, eating disorders, and substance abuse. The natural history of each condition pre- and post-partum is analyzed, and the evidence for the efficacy of drug treatments, evaluated. Special attention is paid to the potential dangers of different treatment options for both mother and fetus, covering risks of malformation, pregnancy and obstetric risks, neonatal risks, and possible long-term consequences. The risks of not treating a particular condition are also analyzed. On the basis of the available evidence, management guidelines are provided that additionally take into account non-pharmacological options. Closing chapters consider the value of complementary and alternative medicine and ECT and explore future research directions.
650 0 _amedicine.
_9566220
650 0 _aObstetrics.
_9306262
650 0 _aPsychopharmacology.
_9302319
650 0 _aPsychology, clinical.
_9265970
650 1 4 _aMedicine & Public Health.
_9566221
650 2 4 _aPsychopharmacology.
_9302319
650 2 4 _aObstetrics/Perinatology.
_9306263
650 2 4 _aPharmacotherapy.
_9428996
650 2 4 _aClinical Psychology.
_9265974
700 1 _aGalbally, Megan.
_eeditor.
_9453208
700 1 _aSnellen, Martien.
_eeditor.
_9453209
700 1 _aLewis, Andrew.
_eeditor.
_9453210
710 2 _aSpringerLink (Online service)
_9143950
773 0 _tSpringer eBooks
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-642-54562-7
912 _aZDB-2-SME
999 _c402875